Therapy of isolated locoregional recurrent carcinoma of the breast.
Lena GabrielMarina SchmidtStephanie Juhasz-BössPatrick MelchiorAnika von HeesenGilda SchmidtNicole KranzhöferErich-Franz SolomayerIngolf Juhasz-BössGeorg-Peter BreitbachPublished in: Archives of gynecology and obstetrics (2019)
Almost all patients with ILRR were operated. Especially patients with hormone receptor-negative recurrent breast cancer seemed to show a benefit having been treated with chemotherapy. Most patients were without recurrence after their particular therapies.